Nevro's low P/S ratio may be due to its poor revenue outlook. Shareholders accept this as they anticipate no future revenue surprises. These conditions could continue to limit the share price.
Nevro's growth strategy, prioritizing expansion over steady profits, is viewed as risky, leading to a rapidly declining share price. Despite insider purchases, the company's overall performance has been disappointing, resulting in an annual loss of 8% for shareholders over five years.
Insiders buying shares over the past year, including one at a price higher than current, signals positive views of the company's future. While no insider transactions happened in recent three months, activities over the year suggest firm belief in potential.
The disappointing performance of Nevro's stock may be due to low growth and profit rates. Despite insider purchases, market sentiment towards Nevro remains negative, possibly an overreaction.
Despite Nevro's stock price plummeting, insiders buying shares in the past year, the company's ascent looks doubtful without significant profits and revenue growth.